Table 2.
Clinico-laboratory correlates
|
Global weakness
|
Present (n = 5)
|
Absent (n = 16)
|
p value
|
| Age - mean (SD) years |
7.3(2) |
10.5(3.3) |
0.04 |
| CRP - mean (SD) mg/l |
52(81) |
4(4.5) |
0.03 |
| ESR - mean (SD) mm/hr |
83(41) |
24(25) |
0.007 |
|
Contractures
|
Present (n = 8)
|
Absent (n = 13)
|
|
| Age - mean (SD) years |
6.8(3) |
11.6(2) |
0.0003 |
| CRP - mean (SD) mg/l |
45(75) |
3.8(3.9) |
0.000 |
| ESR - mean (SD) mm/hr |
59(48) |
25(26) |
0.04 |
|
Calcinosis
|
Present (n = 15)
|
Absent (n = 6)
|
|
| Age-mean (SD) years |
9.1(3.5) |
11.3(2) |
0.18 |
| Duration of follow-up - mean (SD) (months) |
39 (28) |
13(14) |
0.04 |
| CK - mean (SD) IU/l |
288 (402) |
2414(3201) |
0.02 |
| Aldolase mean (SD) IU/ |
18.5 (12.6) |
38.6(23.5) |
0.03 |
| Vasculitis (%) |
11(73.3) |
0 (0) |
0.003 |
|
Staphylococcus aureus
infection (%) |
7 (46,7) |
0 (0) |
0.04 |
|
Staphylococcus aureus infection
|
Present (n = 7)
|
Absent (n = 14)
|
|
| Duration of follow-up - mean (SD) (months) | 51(32) | 22(20) | 0.02 |